Publication Date
In 2025 | 0 |
Since 2024 | 0 |
Since 2021 (last 5 years) | 0 |
Since 2016 (last 10 years) | 2 |
Since 2006 (last 20 years) | 4 |
Descriptor
Autism | 4 |
Behavior Problems | 4 |
Children | 4 |
Check Lists | 3 |
Pervasive Developmental… | 3 |
Symptoms (Individual… | 3 |
Adolescents | 2 |
Attention Deficit Disorders | 2 |
Attention Deficit… | 2 |
Drug Therapy | 2 |
Hyperactivity | 2 |
More ▼ |
Source
Autism: The International… | 1 |
Autism: The International… | 1 |
Journal of Mental Health… | 1 |
Journal of the American… | 1 |
Author
Aman, Michael G. | 3 |
Arnold, L. Eugene | 1 |
Bearss, Karen | 1 |
Bodfish, James | 1 |
Brøndbo, Per Håkan | 1 |
Chowdhury, Monali | 1 |
Cook, Amelia M. | 1 |
Deng, Yanhong | 1 |
Goodwin, Matthew | 1 |
Groden, June | 1 |
Hall, Kristy L. | 1 |
More ▼ |
Publication Type
Journal Articles | 4 |
Reports - Research | 3 |
Reports - Evaluative | 1 |
Education Level
Audience
Location
Norway | 1 |
Laws, Policies, & Programs
Assessments and Surveys
Aberrant Behavior Checklist | 4 |
Vineland Adaptive Behavior… | 2 |
Autism Diagnostic Observation… | 1 |
Mullen Scales of Early… | 1 |
Obsessive Compulsive Scale | 1 |
Stanford Binet Intelligence… | 1 |
Strengths and Difficulties… | 1 |
What Works Clearinghouse Rating
Halvorsen, Marianne; Aman, Michael G.; Mathiassen, Børge; Brøndbo, Per Håkan; Steinsvik, Oddmar Ole; Martinussen, Monica – Journal of Mental Health Research in Intellectual Disabilities, 2019
Introduction: Although the Aberrant Behavior Checklist (ABC) is one of the most widely used behavioral rating scales among people with developmental disabilities, very few studies have examined the factor structure of the non-English versions. Methods: The construct validity of the Norwegian ABC was examined in a clinical sample of children and…
Descriptors: Foreign Countries, Check Lists, Behavior Problems, Psychometrics
Woodard, Cooper; Groden, June; Goodwin, Matthew; Bodfish, James – Autism: The International Journal of Research & Practice, 2007
We used a mixed group/single-case, double-blind, placebo-controlled, ABAB design to examine the safety and efficacy of the glutamate antagonist dextromethorphan for the treatment of problematic behaviors and core symptoms in eight children diagnosed with autism. All participants had increased levels of irritability at baseline as measured by the…
Descriptors: Drug Therapy, Behavior Problems, Symptoms (Individual Disorders), Children
Chowdhury, Monali; Aman, Michael G.; Lecavalier, Luc; Smith, Tristram; Johnson, Cynthia; Swiezy, Naomi; McCracken, James T.; King, Bryan; McDougle, Christopher J.; Bearss, Karen; Deng, Yanhong; Scahill, Lawrence – Autism: The International Journal of Research and Practice, 2016
Previously, we adapted the Home Situations Questionnaire to measure behavioral non-compliance in everyday settings in children with pervasive developmental disorders. In this study, we further revised this instrument for use in autism spectrum disorder and examined its psychometric properties (referred to as the Home Situations…
Descriptors: Factor Structure, Psychometrics, Questionnaires, Pervasive Developmental Disorders
Atomoxetine for Hyperactivity in Autism Spectrum Disorders: Placebo-Controlled Crossover Pilot Trial
Arnold, L. Eugene; Aman, Michael G.; Cook, Amelia M.; Witwer, Andrea N.; Hall, Kristy L.; Thompson, Susan; Ramadan, Yaser – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: To explore placebo-controlled efficacy and safety of atomoxetine (ATX) for attention-deficit/hyperactivity disorder (ADHD) symptoms in children with autism spectrum disorders (ASD). Method: Children ages 5 to 15 with ASD and prominent ADHD symptoms were randomly assigned to order in a crossover of clinically titrated ATX and placebo, 6…
Descriptors: Hyperactivity, Autism, Drug Therapy, Attention Deficit Disorders